ADCT
Price
$2.63
Change
-$0.06 (-2.24%)
Updated
Aug 11, 11:24 AM (EDT)
Capitalization
300.86M
One day until earnings call
CLRB
Price
$4.60
Change
-$0.13 (-2.75%)
Updated
Aug 11, 12:54 PM (EDT)
Capitalization
13.51M
7 days until earnings call
Interact to see
Advertisement

ADCT vs CLRB

Header iconADCT vs CLRB Comparison
Open Charts ADCT vs CLRBBanner chart's image
ADC Therapeutics SA
Price$2.63
Change-$0.06 (-2.24%)
Volume$100
Capitalization300.86M
Cellectar Biosciences
Price$4.60
Change-$0.13 (-2.75%)
Volume$140
Capitalization13.51M
ADCT vs CLRB Comparison Chart in %
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. CLRB commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and CLRB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (ADCT: $2.68 vs. CLRB: $4.73)
Brand notoriety: ADCT and CLRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 82% vs. CLRB: 11%
Market capitalization -- ADCT: $300.86M vs. CLRB: $13.51M
ADCT [@Biotechnology] is valued at $300.86M. CLRB’s [@Biotechnology] market capitalization is $13.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileCLRB’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • CLRB’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than CLRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 3 TA indicator(s) are bullish while CLRB’s TA Score has 4 bullish TA indicator(s).

  • ADCT’s TA Score: 3 bullish, 5 bearish.
  • CLRB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CLRB is a better buy in the short-term than ADCT.

Price Growth

ADCT (@Biotechnology) experienced а -0.37% price change this week, while CLRB (@Biotechnology) price change was +0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

ADCT is expected to report earnings on Aug 12, 2025.

CLRB is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADCT($301M) has a higher market cap than CLRB($13.5M). ADCT YTD gains are higher at: 34.673 vs. CLRB (-47.269). CLRB has less debt than ADCT: CLRB (474K) vs ADCT (123M).
ADCTCLRBADCT / CLRB
Capitalization301M13.5M2,230%
EBITDA-95.64MN/A-
Gain YTD34.673-47.269-73%
P/E RatioN/AN/A-
Revenue75.8MN/A-
Total Cash195MN/A-
Total Debt123M474K25,949%
FUNDAMENTALS RATINGS
CLRB: Fundamental Ratings
CLRB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTCLRB
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 18 days ago
78%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMPY3.560.11
+3.19%
Amplify Energy Corp
APAM46.100.84
+1.86%
Artisan Partners Asset Management
LPTX0.32N/A
-0.06%
Leap Therapeutics
GIS49.83-0.32
-0.64%
General Mills
SIBN15.68-0.64
-3.92%
SI-BONE

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with VTYX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then VTYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+1.52%
VTYX - ADCT
47%
Loosely correlated
+19.07%
QTTB - ADCT
46%
Loosely correlated
-16.41%
CLRB - ADCT
40%
Loosely correlated
+0.42%
NRIX - ADCT
39%
Loosely correlated
-2.28%
RXRX - ADCT
39%
Loosely correlated
-0.92%
More

CLRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLRB has been loosely correlated with QTTB. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if CLRB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRB
1D Price
Change %
CLRB100%
+0.42%
QTTB - CLRB
66%
Loosely correlated
-16.41%
IBRX - CLRB
42%
Loosely correlated
+1.46%
ADCT - CLRB
40%
Loosely correlated
+1.52%
ANAB - CLRB
36%
Loosely correlated
+3.24%
PRAX - CLRB
35%
Loosely correlated
-2.81%
More